An insurer’s medical loss ratio can show how much premium revenue is allocated to medical care and qualifying quality improvement, but it cannot tell an individual patient whether a denial was justified or a physician whether a claim was paid correctly. To evaluate payment fairness, pair the ratio with claims, appeals, network, and payment evidence rather than treating one financial percentage as a verdict.
What the ratio measures
The Affordable Care Act’s medical loss ratio rules generally require insurers in the individual and small-group markets to spend at least 80 percent of adjusted premium revenue on clinical services and qualifying quality improvement, and insurers in the large-group market at least 85 percent. Applicable adjustments and aggregation rules matter. The remainder is not simply profit: it may include administration, marketing, taxes, and other expenses. CMS describes the calculation and rebate rules in its medical loss ratio materials.
Why a high ratio does not prove good claims handling
Imagine an insurer that pays expensive hospital claims promptly but repeatedly mishandles smaller outpatient claims. Its aggregate medical spending could still be high. The ratio does not report whether a particular denial used the correct medical-necessity standard, whether a network directory was accurate, or how long a provider waited for an explanation. Conversely, a lower ratio by itself does not establish that every claim was improperly denied.
Distinguish health insurance from Medicare plan reporting
Commercial individual and group insurance medical loss ratio rules are not interchangeable with the Medicare Advantage and Part D contract reporting framework. Medicare plans have separate requirements and enforcement mechanisms. Comparing percentages without identifying the market, reporting year, geographic aggregation, and calculation rules can produce misleading rankings. A Medicare plan’s contract-level metric is not a substitute for reviewing a specific patient’s adverse determination.
Follow the money without assuming intent
A lower claims payout can improve an insurer’s financial position under some circumstances, but the effect depends on rebates, risk adjustment, future premiums, contracts, and other costs. A company may also incur substantial expense correcting mistakes or processing appeals. The useful accountability question is not whether the insurer has a profit motive—many organizations do—but whether its procedures and outcomes meet contractual, clinical, and legal obligations.
What patients can examine
Keep the actual denial notice, benefit language, explanation of benefits, provider claim number, and appeal determination. Compare the reason given with the plan document and medical evidence. Ask whether the insurer reviewed the correct codes and dates of service. If the dispute remains unresolved, use the appropriate appeals route rather than arguing that the insurer’s overall medical loss ratio proves wrongdoing. See our medical loss ratio explainer for further context.
What clinicians and billing offices can examine
Track first-pass acceptance, denials by reason code, time to final adjudication, corrected claims, recoupments, and the difference between contracted allowable amounts and actual remittances. Separate rejected submissions from adjudicated denials. Compare similar claims only after adjusting for payer product, service, contract terms, and clinical documentation. A payment dashboard built from clean records is more actionable than a broad accusation about insurer profits.
Where public data helps—and where it stops
CMS publishes medical loss ratio guidance and some reporting materials. Marketplace transparency datasets may contain issuer- and plan-level claims and appeals measures for specified reporting periods. These datasets have limited scope and do not cover every payer or every claim. Read the data dictionary, year, population, and methodology before comparing companies. An apparent trend can reflect a change in denominator or reporting rather than behavior.
Frequently asked questions
Does 85 percent mean the insurer pays 85 percent of every bill? No. It is an aggregate financial measure, not an individual claim reimbursement rate.
Does a rebate mean my denied claim should be paid? No. Rebates and claim appeals are different processes.
Can patients compare two plans? Yes, cautiously, using the same market and reporting period alongside network access, appeals, costs, and service quality.
Authoritative resources
CMS commercial medical loss ratio guidance; CMS Medicare plan medical loss ratio guidance; Marketplace transparency data.
Leave a Reply